Transenterix Inc (NYSEMKT:TRXC) Big Money Sentiment Improved in 2018 Q2 to 2.15

TransEnterix, Inc. (NYSEAMERICAN:TRXC) Corporate Logo

Transenterix Inc’s Sentiment

“Big money sentiment for Transenterix Inc (NYSEMKT:TRXC) in Q2 2018 increased to 2.15, according to SEC filings. So its up 0.51, from 2018Q1’s 1.64. 71 institutional investors started new and increased stock positions, while 33 sold and decreased their stakes in Transenterix Inc so the sentiment is more positive. Funds own 59.38 million shares, up from 50.28 million shares in 2018Q1. Funds holding Transenterix Inc in top 10 decreased from 3 to 2 for a decrease of 1. In total 15 funds closed positions, 18 reduced and 24 increased. Also 47 funds bought new Transenterix Inc stakes.

Significant Transenterix Inc Shareholders

Sv Health Investors Llc owns 7.55 million shares in Transenterix Inc as of Q2 2018. As of Q2 2018, 6.39 million shares of Transenterix Inc are owned by Aisling Capital Llc. Further, Hamilton Lane Advisors Llc reported 115,000 shares in Transenterix Inc equivalent to 0.91% of its fund’s portfolio. The New York-based fund Global X Management Co Llc have invested about 0.2% of the investment manager’s stock portfolio in Transenterix Inc. The California-based fund Eam Investors Llc looks positive on Transenterix Inc, having 245,801 shares.

TransEnterix, Inc., a medical device company, focuses on the development and commercialization of surgical robotic systems.The firm is valued at $652.68 million. The firm offers Senhance System, a multi-port robotic surgery system, which allows up to four arms to control robotic instruments and a camera in Europe.Last it reported negative earnings. It also develops SurgiBot System, a single-port, robotically enhanced laparoscopic surgical platform.

Ticker’s shares touched $3.02 during the last trading session after 5.03% change.TransEnterix, Inc. has volume of 2.48M shares. Since December 8, 2017 TRXC has risen 330.95% and is uptrending. TRXC outperformed by 315.33% the S&P 500.

Earnings report for TransEnterix, Inc. (NYSEAMERICAN:TRXC) is anticipated on March, 5., Faxor reports. Analysts have expectation on stock’s earnings per share of $-0.06. That’s up 85.00 % from last year’s $-0.4 earnings per share. After $-0.06 EPS report previous quarter, Wall Street now forecasts 0.00 % EPS growth of TransEnterix, Inc..

The Minnesota-based Us Financial Bank De has invested 0% in TransEnterix, Inc. (NYSEAMERICAN:TRXC). Maryland Management invested in 0.05% or 80,375 shs. 23,198 are owned by Comerica Fincl Bank. New York-based Millennium Limited Liability has invested 0% in TransEnterix, Inc. (NYSEAMERICAN:TRXC). Citadel Ltd Com holds 0% of its capital in TransEnterix, Inc. (NYSEAMERICAN:TRXC) for 114,672 shs. California Pub Employees Retirement System accumulated 181,463 shs or 0% of the stock. Goldman Sachs Group Inc Inc has invested 0% in TransEnterix, Inc. (NYSEAMERICAN:TRXC). Fifth Third State Bank has 6,450 shs for 0% of their capital. Artemis Inv Mgmt Llp has 1.32 million shs for 0.08% of their capital. Moreover, Jfs Wealth Advsrs Ltd Limited Liability Company has 0% invested in TransEnterix, Inc. (NYSEAMERICAN:TRXC). Masters Mngmt Limited Liability Co holds 1.24 million shs. Wells Fargo & Communications Mn invested in 120,044 shs. Fincl Bank Of America Corporation De invested in 25,650 shs or 0% of the stock. Aqr Capital Llc, Connecticut-based fund reported 403,613 shs. Utd Serv Automobile Association reported 0% of its capital in TransEnterix, Inc. (NYSEAMERICAN:TRXC).

TransEnterix, Inc. registered $30.67 million net activity with 0 insider buys and 8 sales since June 18, 2018. On Monday, June 25 Pope Todd sold $1.78M worth of TransEnterix, Inc. (NYSEAMERICAN:TRXC). Starling William N JR sold 3.61M shs worth $22.72M.

For more TransEnterix, Inc. (NYSEAMERICAN:TRXC) news announced recently go to:,,, or The titles are as follows: “TransEnterix (TRXC) Q2 Revenue Expected to be $6-$6.3 Million –” announced on July 02, 2018, “7 ‘Strong Buy’ Disruptive Stocks You Should Track Now –” on December 08, 2017, “TransEnterix Schedules Third Quarter 2018 Financial and Operating Results Conference Call for November 8, 2018 – Business Wire” with a publish date: October 24, 2018, “TransEnterix, Inc. Reports Progress on Senhance FDA Submission | – OrthoSpineNews” and the last “TransEnterix Announces Dismissal of Federal Securities Class Action – Business Wire” with publication date: October 09, 2017.

TransEnterix, Inc. (NYSEAMERICAN:TRXC) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.